Publicacions en col·laboració amb investigadors/es de Duke University (2)

2014

  1. Antagonism of SET using OP449 enhances the efficacy of tyrosine kinase inhibitors and overcomes drug resistance in myeloid leukemia

    Clinical Cancer Research, Vol. 20, Núm. 8, pp. 2092-2103

2010

  1. PMS2 endonuclease activity has distinct biological functions and is essential for genome maintenance

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, Núm. 30, pp. 13384-13389